The DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies
Abstract
Three Cannabis Based Medicinal Extracts (CBMEs) for sublingual use became available in 2000. A total of 34 'N of 1' studies were undertaken using this novel therapy for patients with chronic, mainly neuropathic, pain and associated symptoms to explore efficacy, tolerability, safety and dosages. Three CBMEs (Delta9 Tetrahydrocannabinol (THC), Cannabidiol (CBD) and a 1:1 mixture of them both) were given over a 12-week period. After an initial open-label period, the CBMEs were used in a randomised, double-blind, placebo controlled, crossover trial. Extracts which contained THC proved most effective in symptom control. Regimens for the use of the sublingual spray emerged and a wide range of dosing requirements was observed. Side-effects were common, reflecting a learning curve for both patient and study team. These were generally acceptable and little different to those seen when other psycho-active agents are used for chronic pain. These initial experiences with CBME open the way to more detailed and extensive studies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Δ9-THC and Sativex®, but not placebo or CBD, reduced the VAS rating of the two worst pain symptoms during the crossover phase.156”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [156]
In the citing paper
“Quality of sleep was improved by all cannabinoid based medications156”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [156]
Citations
Cites
VALIDITY OF THE TRAIL MAKING TEST AS AN INDICATOR OF ORGANIC BRAIN DAMAGE
Reitan, R. M. (1958) · Perceptual and Motor Skills · doi:10.2466/pms.1958.8.3.271 · Cited by 8,167
Triggering Myocardial Infarction by Marijuana
Mittleman, M. A., Lewis, R. A., Maclure, M., Sherwood, J. B., & Muller, J. E. (2001) · Circulation · doi:10.1161/01.cir.103.23.2805 · Cited by 767
Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669
Action of cannabidiol on the anxiety and other effects produced by ?9-THC in normal subjects
Zuardi, A. W., Shirakawa, I., Finkelfarb, E., & Karniol, I. G. (1982) · Psychopharmacology · doi:10.1007/bf00432554 · Cited by 608
Psychiatric effects of cannabis
Johns, A. R. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.2.116 · Cited by 468
Wade, D. T., Robson, P., House, H., Makela, P., & Aram, J. (2003) · Clinical Rehabilitation · doi:10.1191/0269215503cr581oa · Cited by 441
Campbell, F. A., Tramèr, M. R., Carroll, D., Reynolds, D. J. M., Moore, R. A., & McQuay, H. J. (2001) · BMJ · doi:10.1136/bmj.323.7303.13 · Cited by 422
Marijuana and medicine: assessing the science base
(1999) · Choice Reviews Online · doi:10.5860/choice.37-2206 · Cited by 409
The n-of-1 Randomized Controlled Trial: Clinical Usefulness
Guyatt, G., Keller, J. L., Jaeschke, R., Rosenbloom, D., Adachi, J. D., & Newhouse, M. T. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-4-293 · Cited by 320
Iversen, L. L. (2007) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195328240.001.0001 · Cited by 230
Research works printed but not linked: 3
- Coughlan AK, The Adult Memory and Information Processing Battery (AMIPB) Test Manual.
- Notcutt W, 1985, Medicinal cannabis extracts in chronic pain. (5) Cognitive function and blood cannabinoid levels, Journal of Cannabis Therapeutics, 2, 97
- Hansson PT, 2000, Progress in Pain Research and Management
Cited by
Sorted by citations
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
Agonistic properties of cannabidiol at 5-HT1a receptors
Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706
Russo, E. B., & Guy, G. W. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.08.026 · Cited by 608
Black, N., Stockings, E., Campbell, G., Tran, L. T., Zagic, D., Hall, W. D., Farrell, M., & Degenhardt, L. (2019) · The Lancet Psychiatry · doi:10.1016/s2215-0366(19)30401-8 · Cited by 564
Cannabis-based medicines for chronic neuropathic pain in adults
Mücke, M., Phillips, T., Radbruch, L., Petzke, F. W., & Häuser, W. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012182.pub2 · Cited by 606
Safety and side effects of cannabidiol, a Cannabis sativa constituent
Machado Bergamaschi, M., Helena Costa Queiroz, R., Waldo Zuardi, A., & Alexandre S. Crippa, J. (2011) · Current Drug Safety · doi:10.2174/157488611798280924 · Cited by 558
Cannabinoids in medicine: A review of their therapeutic potential
Ben Amar, M. (2006) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2006.02.001 · Cited by 543
McPartland, J. M., Duncan, M., Marzo, V. D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 552
Pain associated with multiple sclerosis: Systematic review and proposed classification
O’Connor, A. B., Schwid, S., Herrmann, D., Markman, J., & Dworkin, R. (2008) · Pain · doi:10.1016/j.pain.2007.08.024 · Cited by 479
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
Lynch, M. E., & Campbell, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03970.x · Cited by 397
Berman, J. S., Symonds, C., & Birch, R. (2004) · Pain · doi:10.1016/j.pain.2004.09.013 · Cited by 362
The Therapeutic Potential of Cannabis and Cannabinoids
Grotenhermen, F., & Müller‐Vahl, K. (2012) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2012.0495 · Cited by 309
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305
Aviram, J. (2017) · Pain Physician · doi:10.36076/ppj.20.5.e755 · Cited by 305
Wang, L., Hong, P. J., May, C., Rehman, Y., Oparin, Y., Hong, C. J. H., Hong, B. Y., AminiLari, M., Gallo, L., Kaushal, A., et al. (2021) · BMJ · doi:10.1136/bmj.n1034 · Cited by 318
Nugent, S. M., Morasco, B. J., O'Neil, M. E., Freeman, M., Low, A., Kondo, K., Elven, C., Zakher, B., Motu'apuaka, M., Paynter, R., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m17-0155 · Cited by 301
Cannabinoids in the management of difficult to treat pain
Russo, E. B. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1928 · Cited by 300
Manzanares, J., Julian, M., & Carrascosa, A. (2006) · Current Neuropharmacology · doi:10.2174/157015906778019527 · Cited by 287
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Peng, J., Fan, M., An, C., Ni, F., Huang, W., & Luo, J. (2022) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13710 · Cited by 315
Cannabidiol: pharmacology and therapeutic targets
Britch, S. C., Babalonis, S., & Walsh, S. L. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05712-8 · Cited by 307
Positive and Negative Effects of Cannabis and Cannabinoids on Health
Cohen, K., Weizman, A., & Weinstein, A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1381 · Cited by 255
Baron, E. P. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13345 · Cited by 268
A systematic review of cannabidiol dosing in clinical populations
Millar, S., Stone, N. L., Bellman, Z. D., Yates, A. S., England, T. J., & O’Sullivan, S. E. (2019) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14038 · Cited by 261
Cannabinoids and the immune system: An overview
Tănăsescu, R., & Constantinescu, C. S. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.12.005 · Cited by 246
BRADY, C. M., Dasgupta, R., Dalton, C. M., Wiseman, O. J., Berkley, K. J., & Fowler, C. J. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1063oa · Cited by 244
Russo, E. B., Guy, G. W., & Robson, P. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790150 · Cited by 228
Systematic Review and Meta-analysis of Cannabis Treatment for Chronic Pain
Martín-Sánchez, E., Furukawa, T. A., Taylor, J., & Martín, J. L. R. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00703.x · Cited by 227
Cannabinoids in health and disease
Kogan, N. M., & Mechoulam, R. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/nkogan · Cited by 227
Freeman, A. M., Petrilli, K., Lees, R., Hindocha, C., Mokrysz, C., Curran, H. V., Saunders, R., & Freeman, T. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.036 · Cited by 232
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
Iskedjian, M., Bereza, B., Gordon, A., Piwko, C., & Einarson, T. R. (2007) · Current Medical Research and Opinion · doi:10.1185/030079906x158066 · Cited by 216
Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., & Spigelman, I. (2006) · Pain · doi:10.1016/j.pain.2006.06.016 · Cited by 207
Pertwee, R. G. (2005) · The AAPS Journal · doi:10.1208/aapsj070364 · Cited by 218
Häuser, W., Finn, D. P., Kalso, E. A., Krcevski‐Škvarč, N., Kress, H. G., Morlion, B. J., Perrot, S., Schäfer, M., Wells, C., & Brill, S. (2018) · European Journal of Pain · doi:10.1002/ejp.1297 · Cited by 211
Cannabidiol in Humans—The Quest for Therapeutic Targets
Zhornitsky, S., & Potvin, S. (2012) · Pharmaceuticals · doi:10.3390/ph5050529 · Cited by 205
Hazekamp, A., Ruhaak, L. R., Zuurman, L., van Gerven, J., & Verpoorte, R. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20574 · Cited by 197
Russo, E. B. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0009 · Cited by 193
The Endocannabinoid System, Cannabinoids, and Pain
Fine, P. G., & Rosenfeld, M. J. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10129 · Cited by 213
Bilbao, A., & Spanagel, R. (2022) · BMC Medicine · doi:10.1186/s12916-022-02459-1 · Cited by 181
Baron, E. P., Lucas, P., Eades, J., & Hogue, O. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0862-2 · Cited by 188
Cannabinoids and cancer: causation, remediation, and palliation
Hall, W., Christie, M. J., & Currow, D. C. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01711-5 · Cited by 171
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Meta-analysis
Meng, H., Johnston, B. C., Englesakis, M. F., Moulin, D. E., & Bhatia, A. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002110 · Cited by 169
Holdcroft, A., Maze, M., Doré, C. J., Tebbs, S., & Thompson, S. G. (2006) · Anesthesiology · doi:10.1097/00000542-200605000-00021 · Cited by 166
Moltke, J., & Hindocha, C. (2021) · Journal of Cannabis Research · doi:10.1186/s42238-021-00061-5 · Cited by 162
The analgesic potential of cannabinoids.
Elikottil, M., Gupta, M., & Gupta, P. (2018) · Journal of Opioid Management · doi:10.5055/jom.2009.0034 · Cited by 141
The effects of cannabinoid administration on sleep: a systematic review of human studies
Gates, P., Albertella, L., & Copeland, J. (2014) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2014.02.005 · Cited by 127
The endocannabinoid system and neuropathic pain
Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2015) · Pain · doi:10.1097/j.pain.0000000000000428 · Cited by 131
Survey of Australians using cannabis for medical purposes
Swift, W., Gates, P., & Dillon, P. (2005) · Harm Reduction Journal · doi:10.1186/1477-7517-2-18 · Cited by 133
Berman, J. S., Lee, J., Cooper, M., Cannon, A., Sach, J., McKerral, S., Taggart, M., Symonds, C., Fishe, K., & Birch, R. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03408_3.x · Cited by 122
Therapeutic potential of cannabis in pain medicine
Hosking, R., & Zajicek, J. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen119 · Cited by 124
Therapeutic potential of cannabinoid medicines
Robson, P. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1529 · Cited by 126
Ebbert, J. O., Scharf, E. L., & Hurt, R. T. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.09.005 · Cited by 128
Pain and Opioids in Cancer Care: Benefits, Risks, and Alternatives
Bennett, M., Paice, J. A., & Wallace, M. S. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_180469 · Cited by 117
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence
Jensen, B., Chen, J. L., Furnish, T. J., & Wallace, M. S. (2015) · Current Pain and Headache Reports · doi:10.1007/s11916-015-0524-x · Cited by 118
Cannabis is more than simply Δ9-tetrahydrocannabinol
Russo, E. B., & McPartland, J. M. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1348-z · Cited by 112
Köfalvi, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-74349-3 · Cited by 110
Lever, I. J., & Rice, A. S. C. (2007) · Springer eBooks · doi:10.1007/978-3-540-33823-9_10 · Cited by 108
Access to cannabidiol without a prescription: A cross-country comparison and analysis
McGregor, I. S., Cairns, E. A., Abelev, S. V., Cohen, R., Henderson, M., Couch, D., Arnold, J. C., & Gauld, N. J. (2020) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2020.102935 · Cited by 114
Role of Cannabinoids in Multiple Sclerosis
Zajicek, J., & Apostu, V. I. (2011) · CNS Drugs · doi:10.2165/11539000-000000000-00000 · Cited by 106
Cannabinoids in Chronic Non-Cancer Pain: A Systematic Review and Meta-Analysis
Johal, H. S., Devji, T., Chang, Y., Simone, J. J., Vannabouathong, C., & Bhandari, M. (2020) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/1179544120906461 · Cited by 105
AminiLari, M., Wang, L., Neumark, S., Adli, T., Couban, R., Giangregorio, A., Carney, C. E., & Busse, J. W. (2021) · SLEEP · doi:10.1093/sleep/zsab234 · Cited by 104
Use of cannabidiol (CBD) for the treatment of chronic pain
Urits, I., Gress, K. L., Charipova, K., Habib, K., Lee, D. M., Lee, C. S., Jung, J. W., Kassem, H., Cornett, E. M., Paladini, A., et al. (2020) · Best practice & research. Clinical anaesthesiology · doi:10.1016/j.bpa.2020.06.004 · Cited by 111
Cannabinoid derivatives and the pharmacological management of pain
Lessa, M. A., Cavalcanti, I. L., & Figueiredo, N. V. (2016) · Revista Dor · doi:10.5935/1806-0013.20160012 · Cited by 104
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Karst, M., Wippermann, S., & Ahrens, J. (2010) · Drugs · doi:10.2165/11585260-000000000-00000 · Cited by 91
The safety and efficacy of low oral doses of cannabidiol: An evaluation of the evidence
Arnold, J. C., McCartney, D., Suraev, A. S., & McGregor, I. S. (2022) · Clinical and Translational Science · doi:10.1111/cts.13425 · Cited by 90
Recent Advances in the Pharmacological Management of Pain
Guindon, J., Walczak, J., & Beaulieu, P. (2007) · Drugs · doi:10.2165/00003495-200767150-00002 · Cited by 90
A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting
Ware, M. A. (2008) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s1132 · Cited by 89
Abraham, T. T., Lowe, R. H., Pirnay, S., Darwin, W. D., & Huestis, M. A. (2007) · Journal of Analytical Toxicology · doi:10.1093/jat/31.8.477 · Cited by 89
Cannabinoid Analgesia as a Potential New Therapeutic Option in the Treatment of Chronic Pain
Burns, T. L., & Ineck, J. R. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g217 · Cited by 84
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
Davis, M. P. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.17.1.85 · Cited by 82
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands
Davis, M. P. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.918603 · Cited by 81
McCarberg, B. H., & Barkin, R. L. (2007) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e3180a5e581 · Cited by 76
Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain
Seltzman, H. H., Shiner, C., Hirt, E. E., Gilliam, A. F., Thomas, B. F., Maitra, R., Snyder, R. W., Black, S. R., Patel, P. R., Mulpuri, Y., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00516 · Cited by 75
Bell, A. D., MacCallum, C., Margolese, S., Walsh, Z., Wright, P., Daeninck, P. J., Mandarino, E., Lacasse, G., Kaur Deol, J., de Freitas, L., et al. (2024) · Cannabis & Cannabinoid Research · doi:10.1089/can.2021.0156 · Cited by 78
“Sleep issues are often a target symptom for cannabis use and 25 of the studies assessed impacts of CBMs on sleep, including 16 RCTs, 47–49,52–55,57–60,65–67,74,75 four cross-sectional survey studies, 79,80,82,87 three pre-post style studies, 70,73,85 and two case series studies.”
BackgroundEmerging properties of cannabinoid medicines in management of multiple sclerosis
Pryce, G., & Baker, D. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.03.006 · Cited by 76
A Balanced Approach for Cannabidiol Use in Chronic Pain
Argueta, D. A., Ventura, C. M., Kiven, S. B., Sagi, V., & Gupta, K. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00561 · Cited by 78
Cannabis and cannabinoids for symptomatic treatment for people with multiple sclerosis
Filippini, G., Minozzi, S., Borrelli, F., Cinquini, M., & Dwan, K. (2022) · Cochrane Database Systematic Reviews · doi:10.1002/14651858.cd013444.pub2 · Cited by 75
Medicinal Uses of Marijuana and Cannabinoids
Grotenhermen, F., & Müller‐Vahl, K. (2016) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2016.1265360 · Cited by 72
Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations
Arout, C. A., Edens, E., Petrakis, I. L., & Sofuoglu, M. (2015) · CNS Drugs · doi:10.1007/s40263-015-0255-x · Cited by 80
Lowe, R. H., Karschner, E. L., Schwilke, E. W., Barnes, A. J., & Huestis, M. A. (2007) · Journal of Chromatography A · doi:10.1016/j.chroma.2007.06.069 · Cited by 73
Arout, C. A., Haney, M., Herrmann, E. S., Bedi, G., & Cooper, Z. D. (2021) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.14973 · Cited by 69
The intersection between cannabis and cancer in the United States
Bowles, D. W., O’Bryant, C. L., Camidge, D. R., & Jimeno, A. (2011) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2011.09.008 · Cited by 66
Rabgay, K., Waranuch, N., Chaiyakunapruk, N., Sawangjit, R., Ingkaninan, K., & Dilokthornsakul, P. (2019) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2019.07.015 · Cited by 69
Aggarwal, S. K. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31824c5e4c · Cited by 62
A Conversion of oral cannabidiol to delta9-tetrahydrocannabinol seems not to occur in humans
Nahler, G., Grotenhermen, F., Zuardi, A. W., & Crippa, J. A. S. (2017) · Cannabis & Cannabinoid Research · doi:10.1089/can.2017.0009 · Cited by 61
The use of cannabis in supportive care and treatment of brain tumor
Likar, R., & Nahler, G. (2017) · Neuro-Oncology Practice · doi:10.1093/nop/npw027 · Cited by 61
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1560-2_18 · Cited by 62
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
Fox, A., & Bevan, S. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.6.695 · Cited by 60
Bebee, B., Taylor, D. M., Bourke, E. M., Pollack, K., Foster, L., Ching, M. S., & Wong, A. (2021) · The Medical Journal of Australia · doi:10.5694/mja2.51014 · Cited by 63
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Henson, J. D., Vitetta, L., & Hall, S. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01020-z · Cited by 62
POST‐SURGICAL NEUROPATHIC PAIN
Shipton, E. A. (2008) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2008.04569.x · Cited by 60
Zeng, L., Lytvyn, L., Wang, X., Kithulegoda, N., Agterberg, S., Shergill, Y., Esfahani, M. A., Heen, A. F., Agoritsas, T., Guyatt, G. H., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2021-050831 · Cited by 59
An evaluation of the quality of medicinal grade cannabis in the Netherlands
Hazekamp, A. (2006) · Cited by 57
Therapeutic Uses of Cannabis on Sleep Disorders and Related Conditions
Choi, S., Huang, B. C., & Gamaldo, C. E. (2019) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0000000000000617 · Cited by 56
Goodwin, R. S., Gustafson, R. A., Barnes, A. J., Nebro, W., Moolchan, E. T., & Huestis, M. A. (2006) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200608000-00010 · Cited by 56
Kamal, B., Kamal, F., & Lantela, D. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00730 · Cited by 59
Medical Cannabis for Chronic Nonmalignant Pain Management
Hameed, M., Prasad, S., Jain, E., Doğrul, B. N., Al-Oleimat, A., Pokhrel, B., Chowdhury, S., Co, E. L., Mitra, S., Quinonez, J., et al. (2023) · Current Pain and Headache Reports · doi:10.1007/s11916-023-01101-w · Cited by 62
Cannabis in India: ancient lore and modern medicine
Russo, E. B. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7358-x_1 · Cited by 54
de Vries, M., Van Rijckevorsel, D. C. M., Vissers, K. C. P., Wilder‐Smith, O. H. G., & Van Goor, H. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12811 · Cited by 54
Metadata
- Authors
- Notcutt, W., Price, M., Miller, R., Newport, S., Phillips, C., Simmons, S., & Sansom, C.
- Affiliations
- James Paget University Hospital (GB)
- ORCID
- Notcutt, William
- Venue
- Anaesthesia
- Publisher
- Wiley
- Published
- 2004-04-16
- Volume
- 59
- Issue
- 5
- Pages
- 440-452
- ISSN
- 0003-2409 (ISSN-L)
- 1365-2044
- OpenAlex
- W2148726807
- Cited by
- 305
- References
- 28
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 10 · 2023: 17 · 2022: 24 · 2021: 19 · 2020: 23 · 2019: 14 · 2018: 14 · 2017: 11 · 2016: 7 · 2015: 10 · 2014: 9 · 2013: 4 · 2012: 8
- FWCI
- 15.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Anaesthesia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- GW Pharmaceuticals
- Multiple Sclerosis Society
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Keywords
- chronic pain, neuropathic pain, sublingual administration, delta-9-tetrahydrocannabinol, cannabidiol, THC:CBD ratio, symptom management, dosing regimen, N-of-1 studies
- MeSH terms
- Administration, Sublingual, Adult, Aged, Cannabidiol, Chronic Disease, Depressive Disorder, Double-Blind Method, Drug Combinations, Female, Humans, Male, Middle Aged, Multiple Sclerosis, Pain, Pain Measurement, Sleep, Dronabinol, Treatment Outcome, Patient Selection, Cross-Over Studies, Analgesics, Non-Narcotic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review